申联生物：UBI合计减持1.73%公司股份

Core Viewpoint - United Biomedical, Inc. (UBI) has reduced its stake in Shenglian Biological (688098.SH) by 7.104 million shares, representing 1.73% of the company's total share capital, which has decreased UBI's ownership from 10.00% to 8.27% [1] Group 1 - UBI's share reduction occurred between December 4, 2025, and January 30, 2026 [1] - The reduction included 1.97104 million shares sold through centralized bidding and 5.133 million shares sold via block trading [1] - The equity change triggered a notification as it touched the 1% threshold [1]